PCVX compared with ASND: revenue, margins and what each company keeps, and the suppliers and customers both name

PCVXVaxcyte, Inc.

Mkt capRevenueRevenue

ASNDAscendis Pharma A/S

Mkt capRevenueRevenue

Compare

PCVXVaxcyte, Inc.

ASNDAscendis Pharma A/S

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

rebased to 0%

PCVX, solidASND, dashed

Supply-chain overlap

Revenue flow

PCVX: latest quarter not drawable. ASND: latest quarter not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only PCVX 4

TMOPatheon Manufacturing Services LLC, part of Thermo Fisher Scientific (collectively, "Thermo Fisher")supplier

—Lonzaunlistedsupplier

—Sutro Biopharmaunlistedsupplier

—University of California, San Diegounlistedsupplier

Shared 0

No shared counterparties.

Only ASND 3

NVONovo Nordisk A/Scustomer

—Teijinunlistedcustomer

—VISEN Pharmaceuticalsunlistedcustomer

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

PCVXVaxcyte, Inc.

60.82· pre 60.82· delayed

Mkt cap$9.0B

ASNDAscendis Pharma A/S

250.23· pre 250.23· delayed

Pre-marketNov 3 '26delayed

Mkt cap$15.5B

Compare

Pre-marketNov 3 '26delayed

PCVXVaxcyte, Inc.

ASNDAscendis Pharma A/S

60.82pre 60.82delayed

Price

250.23pre 250.23delayed

$9.0B

Mkt cap

$15.5B

PCVX60.82vsASND250.23Pre-marketNov 3 '26delayed